AAV-VEC Rep-Cap plasmid (serotype VEC - specific AAV RC-VEC plasmids) (Amp and Kanamycin) (GeneMedi Owned)

GeneMedi's AAV-VEC Rep-Cap plasmid supplies the AAV2 Rep (replication) proteins and the AAV-VEC capsid protein.

You can produce AAV-VEC particle in 293T cell line in high titer using GeneMedi's AAV-VEC Rep-Cap plasmid with GM's AAV expression vector (overexpression or shRNA) and AAV helper plasmid.

The tissue tropism of AAV-VEC vector has been validated in endothelium, with potential applications in tissue-specific gene therapy.

GeneMedi offers both Ampicillin (Amp) resistance and Kanamycin (Kan) resistance for the AAV Rep-Cap Plasmids.

Target products collectionGo to AAV vector system >>


Product Description

Cat.NO Product Name Organization Type Price(In USD)
P-RC26 AAV-VEC Rep-Cap Plasmid (Amp resistance)
Size:5ug
Academic 2062
P-RC26 AAV-VEC Rep-Cap Plasmid (Amp resistance)
Size:5ug
Industry R&D
(excluding
CRO&CDMO&CXO)
P-RC26 AAV-VEC Rep-Cap Plasmid (Amp resistance)
Size:5ug
CRO&CDMO&
CXO&CMC&
Manufacturing company
P-RC26 AAV-VEC Rep-Cap Plasmid (Amp resistance)
Size:≥10mg
All
P-RC26-Kan AAV-VEC Rep-Cap Plasmid (Kan resistance)
Size:≥10mg
All
P-PK26 AAV-VEC Vector System (Amp resistance)
1. AAV-VEC Rep-Cap Plasmid, 5ug
2. AAV Helper Plasmid, 5ug
3. pGMAAV-CMV-MCS-T2A-ZsGreen (P-AAVV-B01), 5ug
Academic 3379
P-PK26 AAV-VEC Vector System (Amp resistance)
1. AAV-VEC Rep-Cap Plasmid, 5ug
2. AAV Helper Plasmid, 5ug
3. pGMAAV-CMV-MCS-T2A-ZsGreen (P-AAVV-B01), 5ug
Industry R&D
(excluding
CRO&CDMO&CXO)
P-PK26 AAV-VEC Vector System (Amp resistance)
1. AAV-VEC Rep-Cap Plasmid, 5ug
2. AAV Helper Plasmid, 5ug
3. pGMAAV-CMV-MCS-T2A-ZsGreen (P-AAVV-B01), 5ug
CRO&CDMO&
CXO&CMC&
Manufacturing company
P-PK26 AAV-VEC Vector System (Amp resistance)
1. AAV-VEC Rep-Cap Plasmid, ≥10mg
2. AAV Helper Plasmid, ≥10mg
3. pGMAAV-CMV-MCS-T2A-ZsGreen (P-AAVV-B01-Kan), ≥10mg
All
P-PK26-Kan AAV-VEC Vector System(Kan resistance)
1. AAV-VEC Rep-Cap Plasmid(Kan resistance), ≥10mg
2. AAV Helper Plasmid(Kan resistance), ≥10mg
3. pGMAAV-CMV-MCS-T2A-ZsGreen (Kan resistance) (P-AAVV-B01-Kan), ≥10mg
All
GeneMedi offers both seed and amplification services for the Amp-resistant AAV Rep-Cap Plasmid.
GeneMedi only offers amplification services and do not provide seed for the Kan-resistant AAV Rep-Cap Plasmid currently.
If you want to obtain higher quantities of plasmids (mg), please visit GM TransExcellent Plasmid DNA Rapid Preparation Service.
Terms of sale:
For Seed (5ug):
The purchaser may not reverse engineer this product to extract the sequence for independent use. The purchaser may not transfer this product to others for manufacturing purposes. The purchaser may not use this material to manufacture this product for any other party.

For plasmid production& amplification (≥10mg):
The purchaser may not reverse engineer this product to extract the sequence for independent use. The purchaser may not transfer this product to others for manufacturing purposes. The purchaser may not use this material to manufacture this product for themselves or any other party.

Citation

Title Publication Date
CB1R-stabilized NLRP3 inflammasome drives antipsychotics cardiotoxicity Signal Transduction and Targeted Therapy 2022/6/24
Exosomes derived from osteogenic tumor activate osteoclast differentiation and concurrently inhibit osteogenesis by transferring COL1A1-targeting miRNA-92a-1-5p Journal of Extracellular Vesicles 2021/1/18
SUPPLEMENTARY MATERIALS AND METHODS Ann Rheum Dis
Engineered biomimetic nanoparticles achieve targeted delivery and efficient metabolism-based synergistic therapy against glioblastoma nature communications 2022/7/21
The deubiquitylase OTUD3 stabilizes GRP78 and promotes lung tumorigenesis Nature Communications 2019/7/2
VDR Activation Attenuates Renal Tubular Epithelial Cell Ferroptosis by Regulating Nrf2/HO-1 Signaling Pathway in Diabetic Nephropathy Advanced Science 2023/12/25
Improving cancer immunotherapy via co-delivering checkpoint blockade and thrombospondin-1 downregulator Acta Pharmaceutica Sinica B 2022/7/21
Loss of Hilnc prevents diet-induced hepatic steatosis through binding of IGF2BP2 nature metabolism 2021/11/8
ABRO1 arrests postnatal cardiomyocyte proliferation and myocardial repair by blocking N6-methyladenosine methylation and expression of PSPH Molecular Therapy 2023/1/13
The Involvement of PGRMC1Signaling in Cognitive Impairment Induced by Long-Term Clozapine Treatment in Rats Neuropsychobiology 2023/9/6


Validation data

No data found


Associated products and services


Products & Service Products & Service Information
AAV Packaging service Detail
Promise-ORF™ viral CDNA library Detail
Plasmid DNA Rapid Preparation Service Detail